Alcon and LENSAR have decided to terminate a previously agreed-upon merger due to scrutiny from the US Federal Trade Commission (FTC). 1,2. The merger, originally announced in Mar ...
Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...
In this video, a visually impaired speaker discusses Mr. Beast's recent effort to pay for cataract surgeries for 1,000 people ...
Enhancement coverage applies within 24 months of the original procedure for refractive and premium lens pathways. Beyond this ...
The Leader on MSN
Average NHS Wales waiting time hits lowest level in almost six years
NHS waiting times have fallen once more, the Welsh Government has said.
Hospital waiting lists in Wales have seen a record drop as the latest figures indicate the total number of patients waiting ...
Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.
One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...
Anti-VEGF use for ROP is expanding beyond bevacizumab and ranibizumab, with aflibercept’s fusion-protein structure conferring systemic exposure characteristics distinct from antibody-based agents.
The A.A.O. recommends that adults with no signs or risk factors for eye disease get a comprehensive exam at 40 to establish a ...
The Welsh Government says that it is the eighth month in a row that the waiting list has fallen, but targets for cancer ...
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results